Print

Eleven Biotherapeutics to Present at the Association for Research in Vision & Ophthalmology 2012 Annual Meeting  
4/24/2012 10:35:57 AM

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Eleven Biotherapeutics, a biopharmaceutical company designing and engineering novel and differentiated protein-based biotherapeutics, announced today that a poster presentation on its lead drug candidate EBI-005, has been selected for presentation at the Association for Research in Vision and Ophthalmology (ARVO) 2012 Annual Meeting taking place May 6-10, 2012, in Ft. Lauderdale, FL.
//-->